கலப்பபகோ பத்திரங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கலப்பபகோ பத்திரங்கள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கலப்பபகோ பத்திரங்கள் Today - Breaking & Trending Today

Investegate |Galapagos NV Announcements | Galapagos NV: Galapagos reports H1 financial results with refocused pipeline and operational progress

Investegate |Galapagos NV Announcements | Galapagos NV: Galapagos reports H1 financial results with refocused pipeline and operational progress
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

Region Flamande , United States , United Kingdom , Great Britain , Van Gijsel , Elizabeth Goodwin , Bart Filius , Sandra Cauwenberghs , Carmen Vroonen , European Commission , Gilead Sciences Inc , Regulatory Agency , Exchange Commission , Japanese Ministry Of Health , Global Head Of Communications Public Affairs , Committee For Medicinal Products Human Use , Standard International , Europe Following , Belgian Government , Medicinal Products , Human Use , Japanese Ministry , Gilead Sciences , Galapago Securities , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் ,

Galapagos NV: Galapagos refocuses pipeline and rightsizes operations

Galapagos NV: Galapagos refocuses pipeline and rightsizes operations
Filgotinib launch in Europe on track
Initiated
unaudited
the
.
These last months, we completed a review of our portfolio and development plans with the goal to select a more risk-balanced pipeline. We decided to retain our focus on novel targets to address unmet medical needs in inflammation, fibrosis, and kidney diseases. We also remain fully committed to the launch of Jyseleca in Europe. Moving forward with confidence, we decided to:
Refocus our clinical pipeline by critically examining its risk profile and breadth;
Cut significant cost in the organization to support this re-sized pipeline development; ....

Region Flamande , United Kingdom , Van Gijsel , Elizabeth Goodwin , Raj Parekh , Bart Filius , Carmen Vroonen , Kyra Obolensky , European Commission , Gilead Sciences Inc , Exchange Commission , Japanese Ministry Of Health , Global Head Of Communications Public Affairs , Corporate Communications , Committee For Medicinal Products Human Use , Standard International , Medicinal Products , Human Use , Belgian Government , Katrine Bosley , Japanese Ministry , Gilead Sciences , Galapago Securities , ஒன்றுபட்டது கிஂக்டம் , எலிசபெத் குட்வின் , ராஜ் பரேக் ,

Investegate |Galapagos NV Announcements | Galapagos NV: Galapagos refocuses pipeline and rightsizes operations

.
“These last months, we completed a review of our portfolio and development plans with the goal to select a more risk-balanced pipeline. We decided to retain our focus on novel targets to address unmet medical needs in inflammation, fibrosis, and kidney diseases. We also remain fully committed to the launch of Jyseleca in Europe. Moving forward with confidence, we decided to:
Refocus our clinical pipeline by critically examining its risk profile and breadth;
Cut significant cost in the organization to support this re-sized pipeline development;
Task our business development team to identify and execute on a transformative opportunity.
We believe that our strong cash position, expert teams, and solid scientific foundation position us well for future growth,” said Onno van de Stolpe, CEO of Galapagos. ....

Region Flamande , United States , United Kingdom , Van Gijsel , Elizabeth Goodwin , Raj Parekh , Bart Filius , Carmen Vroonen , Kyra Obolensky , European Commission , Gilead Sciences Inc , Exchange Commission , Japanese Ministry Of Health , Corporate Communications , Global Head Of Communications Public Affairs , Committee For Medicinal Products Human Use , Standard International , Medicinal Products , Human Use , Belgian Government , Katrine Bosley , Japanese Ministry , Gilead Sciences , Galapago Securities , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் ,

Galapagos NV: Pipeline and capital for growth

Galapagos NV: Pipeline and capital for growth
Jyseleca approved for rheumatoid arthritis (RA) in Europe & Japan
Gilead decided not to pursue the RA indication in the U.S. as a result of Complete Response Letter (CRL) from the Food and Drug Administration (FDA)
Galapagos to assume commercialization of Jyseleca in Europe by the end of 2021, first sales achieved
Primary endpoint achieved in SELECTION Phase 3 trial in ulcerative colitis (UC) with Jyseleca, submitted for approval in UC in Europe
Positive topline results in PINTA Phase 2 trial with 1205 in idiopathic pulmonary fibrosis (IPF); no signal with 1972 in ROCCELLA Phase 2b trial in osteoarthritis (OA) ....

Region Flamande , United States , United Kingdom , Van Gijsel , Elizabeth Goodwin , Bart Filius , Carmen Vroonen , Anna Gibbins , European Commission , Drug Administration , Therapeutic Areas Communications , Gilead Sciences Inc , Global Head Communications Public Affairs , Exchange Commission , Japanese Ministry Of Health , Committee For Medicinal Products Human Use , Complete Response Letter , Belgian Government , Medicinal Products , Human Use , Annual Report , Japanese Ministry , Galapago Securities , Gilead Sciences , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் ,

Investegate |Galapagos NV Announcements | Galapagos NV: Pipeline and capital for growth

Investegate |Galapagos NV Announcements | Galapagos NV: Pipeline and capital for growth
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

Region Flamande , United States , United Kingdom , Van Gijsel , Elizabeth Goodwin , Bart Filius , Carmen Vroonen , Anna Gibbins , European Commission , Drug Administration , Therapeutic Areas Communications , Gilead Sciences Inc , Global Head Communications Public Affairs , Exchange Commission , Japanese Ministry Of Health , Committee For Medicinal Products Human Use , Complete Response Letter , Belgian Government , Medicinal Products , Human Use , Publication Annual Report , Annual Shareholder , Japanese Ministry , Galapago Securities , Gilead Sciences , ஒன்றுபட்டது மாநிலங்களில் ,